Wealth Manager - the site for professional investment managers

Register to get unlimited access to all of Citywire’s Fund Manager database. Registration is free and only takes a minute.

HMRC wins court battle against £80m Matrix tax scheme

HMRC wins court battle against £80m Matrix tax scheme

A  tax avoidance scheme promoted by Matrix Securities has been successfully challenged by HM Revenue & Customs (HMRC) in court.

HMRC said the medical research-based tax avoidance scheme had created £77 million in tax relief.

Eighty three investors invested in a Jersey-registered limited partnership, which claimed to be trading in the UK, focused on creating and exploiting intellectual property from research into vaccines targeting diseases such as HIV, flu and hepatitis B.

The investors used £28 million of their own cash and £86 million in bank loans.

The partnership claimed a first-year trading loss of nearly £193 million, creating £77 million in tax relief. This would have given the investors an almost £50 million return on their personal investments.

However, only £14 million had been spent on medical research, HMRC said.

As a result, a tribunal agreed that individual partners were entitled to a tax relief of no more than £14 million and further, that the £7 million in fees that it paid to a subsidiary of the scheme promoters failed to qualify as tax relief.

The interest relief on the loans that had been used in the scheme was also restricted.

Exchequer Secretary David Gauke said: ‘The government is committed to tackling tax avoidance and will close down those schemes that are artificial and contrived ways of exploiting the rules.

‘Significant reinvestment has been made into HMRC to pursue and challenge the tax dodgers and they will take decisive action to close down schemes with the sole purpose of avoiding paying tax.’

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Brewin's Gutteridge & Foster talk property with Standard Life's Baggaley

Brewin's Gutteridge & Foster talk property with Standard Life's Baggaley

Gutteridge and Foster discuss UK commercial property with Jason Baggaley, manager of the Standard Life Property Income investment trust

Brewin's Gutteridge asks Odey's Tim Bond two tough questions

Brewin's Gutteridge asks Odey's Tim Bond two tough questions

Gutteridge puts the heat on Odey's asset allocation maestro with a couple of tough questions.

Brewin's Foster & Gutteridge: searching for the yield of dreams

Brewin's Foster & Gutteridge: searching for the yield of dreams

Guy Foster and Ben Gutteridge discuss the latest upbeat US payroll report and how it has increased the probability of a first hike in interest rates in June.

Your Business: Cover Star Club

Profile: Creechurch Capital’s CEO on going the extra mile in a crowded market

Profile: Creechurch Capital’s CEO on going the extra mile in a crowded market

Growing a business is the main aim of many company owners but managing that growth in a controlled way is just as important

Wealth Manager on Twitter